標(biāo)題: Titlebook: Myeloid-Derived Suppressor Cells and Cancer; David Escors,James E. Talmadge,Grazyna Kochan Book 2016 The Author(s) 2016 Ex vivo MDSC Diffe [打印本頁] 作者: 鳴叫大步走 時(shí)間: 2025-3-21 18:29
書目名稱Myeloid-Derived Suppressor Cells and Cancer影響因子(影響力)
書目名稱Myeloid-Derived Suppressor Cells and Cancer影響因子(影響力)學(xué)科排名
書目名稱Myeloid-Derived Suppressor Cells and Cancer網(wǎng)絡(luò)公開度
書目名稱Myeloid-Derived Suppressor Cells and Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Myeloid-Derived Suppressor Cells and Cancer被引頻次
書目名稱Myeloid-Derived Suppressor Cells and Cancer被引頻次學(xué)科排名
書目名稱Myeloid-Derived Suppressor Cells and Cancer年度引用
書目名稱Myeloid-Derived Suppressor Cells and Cancer年度引用學(xué)科排名
書目名稱Myeloid-Derived Suppressor Cells and Cancer讀者反饋
書目名稱Myeloid-Derived Suppressor Cells and Cancer讀者反饋學(xué)科排名
作者: 果核 時(shí)間: 2025-3-21 22:27
Book 2016heir role in the tumour microenvironment and their therapeutic targeting. It closes with an outlook on future developments. In cancer patients, myelopoiesis is perturbed and instead of generating immunogenic myeloid cells (such as dendritic cells, inflammatory macrophages and granulocytes), there is作者: Catheter 時(shí)間: 2025-3-22 02:34
Book 2016 promoting their progression and metastasis by inhibiting the natural anti-tumour immune response. As these cells also interact with classical anti-neoplastic treatments, they have become major therapeutic targets in the pharmaceutical industry and in oncology research..作者: 可以任性 時(shí)間: 2025-3-22 05:34
David Escors,James E. Talmadge,Grazyna KochanComprehensively explores the biology and role of MDSCs in cancer.Covers therapeutic targeting via the STAT3 pathway, a major regulatory pathway in MDSCs functions as well as in tumour cells.Particular作者: Oration 時(shí)間: 2025-3-22 09:24 作者: 較早 時(shí)間: 2025-3-22 15:28
https://doi.org/10.1007/978-3-319-26821-7Ex vivo MDSC Differentiation; STAT3 Pathway; Human and Mouse MDSCs; Murine MDSC Differentiation; Myeloid作者: 符合規(guī)定 時(shí)間: 2025-3-22 17:29
Myeloid-Derived Suppressor Cells and Cancer978-3-319-26821-7Series ISSN 2194-2773 Series E-ISSN 2194-2781 作者: obsession 時(shí)間: 2025-3-22 21:26
2194-2773 esponse. As these cells also interact with classical anti-neoplastic treatments, they have become major therapeutic targets in the pharmaceutical industry and in oncology research..978-3-319-26819-4978-3-319-26821-7Series ISSN 2194-2773 Series E-ISSN 2194-2781 作者: 粗糙濫制 時(shí)間: 2025-3-23 03:07
9樓作者: Thymus 時(shí)間: 2025-3-23 05:38
10樓作者: 會(huì)議 時(shí)間: 2025-3-23 12:42
第4樓作者: 藕床生厭倦 時(shí)間: 2025-3-23 13:58
第4樓作者: 千篇一律 時(shí)間: 2025-3-23 18:46
5樓作者: Generosity 時(shí)間: 2025-3-24 01:57
5樓作者: 脫毛 時(shí)間: 2025-3-24 05:49
5樓作者: Suggestions 時(shí)間: 2025-3-24 09:03
5樓作者: 音的強(qiáng)弱 時(shí)間: 2025-3-24 11:41
6樓作者: 一美元 時(shí)間: 2025-3-24 14:58
6樓作者: 他很靈活 時(shí)間: 2025-3-24 19:43
6樓作者: 使迷醉 時(shí)間: 2025-3-25 01:15
6樓作者: Mundane 時(shí)間: 2025-3-25 05:49
7樓作者: 敲詐 時(shí)間: 2025-3-25 08:48
7樓作者: 星星 時(shí)間: 2025-3-25 12:56
7樓作者: Cholecystokinin 時(shí)間: 2025-3-25 16:58
7樓作者: 使成核 時(shí)間: 2025-3-25 23:13
8樓作者: 劇本 時(shí)間: 2025-3-26 00:25
8樓作者: gratify 時(shí)間: 2025-3-26 07:20
8樓作者: 實(shí)施生效 時(shí)間: 2025-3-26 08:30
8樓作者: 宴會(huì) 時(shí)間: 2025-3-26 13:27
9樓作者: CHOKE 時(shí)間: 2025-3-26 20:11
9樓作者: 外星人 時(shí)間: 2025-3-26 22:13
9樓作者: exhilaration 時(shí)間: 2025-3-27 02:40
9樓作者: constitute 時(shí)間: 2025-3-27 08:20
10樓作者: muscle-fibers 時(shí)間: 2025-3-27 09:51
10樓作者: Immortal 時(shí)間: 2025-3-27 14:52
10樓作者: 迫擊炮 時(shí)間: 2025-3-27 20:11
10樓
